Muneyoshi Okada
Impact in
-
- Cardiovascular Disease and Adiposity
- Cardiac Fibrosis and Remodeling
- Clinical Biochemistry top 2%
- Advanced Glycation End Products research
Papers in
-
- Cardiac Fibrosis and Remodeling 25
- Renin-Angiotensin System Studies 11
-
- Signaling Pathways in Disease 12
- Receptor Mechanisms and Signaling 11
- Co-authors
- Hideyuki Yamawaki (113 shared papers)Yukio Hara (42 shared papers)Tatsuya Usui (8 shared papers)Masashi Mukohda (12 shared papers)Satoshi Kameshima (15 shared papers)Kyosuke Kazama (9 shared papers)Tomoka Morita (10 shared papers)Tatsuya Usui (6 shared papers)
In The Last Decade
Muneyoshi Okada
120 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 109
- Cardiology and Cardiovascular Medicine 894
- Clinical Biochemistry 232
- Physiology 739
- Epidemiology 864
- Cancer Research 380
Countries citing papers authored by Muneyoshi Okada
This map shows the geographic impact of Muneyoshi Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muneyoshi Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muneyoshi Okada more than expected).
Fields of papers citing papers by Muneyoshi Okada
This network shows the impact of papers produced by Muneyoshi Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muneyoshi Okada. The network helps show where Muneyoshi Okada may publish in the future.
Co-authors
The 25 scholars most cited alongside Muneyoshi Okada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 263 | |
| 2 | 2010 | 217 | |
| 3 | 2012 | 136 | |
| 4 | 2011 | 105 | |
| 5 | 2012 | 89 | |
| 6 | 2008 | 87 | |
| 7 | 2000 | 85 | |
| 8 | 2012 | 75 | |
| 9 | 2013 | 73 | |
| 10 | 2012 | 72 | |
| 11 | 2009 | 71 | |
| 12 | 2013 | 71 | |
| 13 | 2015 | 65 | |
| 14 | 2014 | 61 | |
| 15 | 2012 | 59 | |
| 16 | 2009 | 56 | |
| 17 | 2006 | 48 | |
| 18 | 2018 | 47 | |
| 19 | 2012 | 46 | |
| 20 | 2008 | 45 |
About Muneyoshi Okada
Muneyoshi Okada is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Physiology, Cancer Research and Epidemiology, having authored 121 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (25 papers), Nitric Oxide and Endothelin Effects (23 papers), Adipokines, Inflammation, and Metabolic Diseases (19 papers), Protease and Inhibitor Mechanisms (17 papers), Adipose Tissue and Metabolism (14 papers), Signaling Pathways in Disease (12 papers), Receptor Mechanisms and Signaling (11 papers) and Renin-Angiotensin System Studies (11 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (894 citations), Clinical Biochemistry (232 citations), Physiology (739 citations), Epidemiology (864 citations) and Cancer Research (380 citations). Muneyoshi Okada has collaborated with scholars based in Japan and China. Frequent co-authors include Hideyuki Yamawaki, Yukio Hara, Tatsuya Usui, Masashi Mukohda, Satoshi Kameshima, Kyosuke Kazama, Tomoka Morita, Tatsuya Usui, Junji Kuramoto and Tomoko Kodama. Their work appears in journals such as Journal of Pharmacological Sciences, Biochemical and Biophysical Research Communications, European Journal of Pharmacology, International Journal of Molecular Sciences and Pflügers Archiv - European Journal of Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.